342 related articles for article (PubMed ID: 32097657)
21. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
22. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
23. Role of TNF in mast cell neuroinflammation and pain.
Gu Y; Yang DK; Spinas E; Kritas SK; Saggini A; Caraffa A; Antinolfi P; Saggini R; Conti P
J Biol Regul Homeost Agents; 2015; 29(4):787-91. PubMed ID: 26753638
[TBL] [Abstract][Full Text] [Related]
24. Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues.
Conti P; Caraffa Al; Kritas SK; Ronconi G; Lessiani G; Toniato E; Theoharides TC
J Biol Regul Homeost Agents; 2017; 31(2):263-267. PubMed ID: 28685525
[TBL] [Abstract][Full Text] [Related]
25. Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines.
Lauritano D; Mastrangelo F; D'Ovidio C; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Trimarchi M; Carinci F; Conti P
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902240
[TBL] [Abstract][Full Text] [Related]
26. New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators.
Caraffa Al; Conti C; D Ovidio C; Gallenga CE; Tettamanti L; Mastrangelo F; Ronconi G; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2018; 32(3):449-454. PubMed ID: 29921369
[TBL] [Abstract][Full Text] [Related]
27. Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).
Conti P; Caraffa A; Ronconi G; Conti CM; Kritas SK; Mastrangelo F; Tettamanti L; Theoharides TC
Immunol Res; 2018 Jun; 66(3):323-331. PubMed ID: 29907890
[TBL] [Abstract][Full Text] [Related]
28. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta.
Lee SA; Fitzgerald SM; Huang SK; Li C; Chi DS; Milhorn DM; Krishnaswamy G
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):283-91. PubMed ID: 15191916
[TBL] [Abstract][Full Text] [Related]
29. Genistein inhibits pro‑inflammatory cytokines in human mast cell activation through the inhibition of the ERK pathway.
Kim DH; Jung WS; Kim ME; Lee HW; Youn HY; Seon JK; Lee HN; Lee JS
Int J Mol Med; 2014 Dec; 34(6):1669-74. PubMed ID: 25319548
[TBL] [Abstract][Full Text] [Related]
30. LXW7 attenuates inflammation via suppressing Akt/nuclear factor kappa B and mitogen-activated protein kinases signaling pathways in lipopolysaccharide-stimulated BV2 microglial cells.
Peng S; Jia J; Sun J; Xie Q; Zhang X; Deng Y; Yi L
Int Immunopharmacol; 2019 Dec; 77():105963. PubMed ID: 31732449
[TBL] [Abstract][Full Text] [Related]
31. Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling.
Li W; Yin N; Tao W; Wang Q; Fan H; Wang Z
Int Immunopharmacol; 2019 Jan; 66():82-90. PubMed ID: 30445310
[TBL] [Abstract][Full Text] [Related]
32. Mast cell and cancer with special emphasis on il-37 an anti-inflammatory and inhibitor of innate immunity: new frontiers.
Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa Al; Conti P
J Biol Regul Homeost Agents; 2016; 30(4):945-950. PubMed ID: 28078840
[TBL] [Abstract][Full Text] [Related]
33. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia.
Delgado M; Leceta J; Ganea D
J Leukoc Biol; 2003 Jan; 73(1):155-64. PubMed ID: 12525573
[TBL] [Abstract][Full Text] [Related]
34. Link between mast cells and bacteria: Antimicrobial defense, function and regulation by cytokines.
Conti P; Carinci F; Caraffa A; Ronconi G; Lessiani G; Theoharides TC
Med Hypotheses; 2017 Sep; 106():10-14. PubMed ID: 28818263
[TBL] [Abstract][Full Text] [Related]
35. A novel immune-to-CNS communication pathway: cells of the meninges surrounding the spinal cord CSF space produce proinflammatory cytokines in response to an inflammatory stimulus.
Wieseler-Frank J; Jekich BM; Mahoney JH; Bland ST; Maier SF; Watkins LR
Brain Behav Immun; 2007 Jul; 21(5):711-8. PubMed ID: 16989980
[TBL] [Abstract][Full Text] [Related]
36. Induction of Microglial Activation by Mediators Released from Mast Cells.
Zhang X; Wang Y; Dong H; Xu Y; Zhang S
Cell Physiol Biochem; 2016; 38(4):1520-31. PubMed ID: 27050634
[TBL] [Abstract][Full Text] [Related]
37. Effect of the semen extract of Cuscuta chinensis on inflammatory responses in LPS-stimulated BV-2 microglia.
Kang SY; Jung HW; Lee MY; Lee HW; Chae SW; Park YK
Chin J Nat Med; 2014 Aug; 12(8):573-81. PubMed ID: 25156282
[TBL] [Abstract][Full Text] [Related]
38. New insight into systemic mastocytosis mediated by cytokines IL-1β and IL-33: Potential inhibitory effect of IL-37.
Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Pandolfi F
Eur J Pharmacol; 2019 Sep; 858():172473. PubMed ID: 31228452
[TBL] [Abstract][Full Text] [Related]
39. 7,8-Dihydroxyflavone attenuates the release of pro-inflammatory mediators and cytokines in lipopolysaccharide-stimulated BV2 microglial cells through the suppression of the NF-κB and MAPK signaling pathways.
Park HY; Park C; Hwang HJ; Kim BW; Kim GY; Kim CM; Kim ND; Choi YH
Int J Mol Med; 2014 Apr; 33(4):1027-34. PubMed ID: 24535427
[TBL] [Abstract][Full Text] [Related]
40. Mast cells as effector cells of innate immunity and regulators of adaptive immunity.
Cardamone C; Parente R; Feo GD; Triggiani M
Immunol Lett; 2016 Oct; 178():10-4. PubMed ID: 27393494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
